A few AACR Runners for Research shared their thoughts as they prepare to pound some pavement and raise money...
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...
AACRoC in Brazil let young investigators learn from cancer research experts during programs in São Paulo and Ribeirão Preto.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Three patients share their experiences about having Lynch syndrome.
Researchers are exploring new options for kidney cancer treatments.
The AACR-Women in Cancer Research constituency group celebrates its 25th anniversary this year.
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
Cody Wolf was one of 19 young scientists who visited Washington for AACR's Early-career Hill Day.
Four of the 2023 GSITA recipients explain how the program has benefited their careers.